Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Caused by Heart Failure With Reduced Ejection Fraction

NCT06078436 is registered in ClinicalTrials.gov with Min-Seok Kim as lead sponsor.

NCT NCT06078436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06078436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Caused by Heart Failure With Reduced Ejection Fraction
Lead sponsor
Min-Seok Kim
Phase
Not applicable
Overall status
Recruiting
Start date
January 31, 2024
Completion date
March 31, 2028
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiogenic shock, heart failure with reduced ejection fraction